Recent Updates
Recently added Catalysts
PTN Positive Sentiment Score: 60/100

Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024

Key Takeaway: Palatin Technologies, Inc. (NYSE American: PTN) is set to announce its first quarter fiscal year 2025 operating results on November 14, 2024. This announcement will be followed by a conference call and live audio webcast at 11:00 a.m. ET, where the company's executive management will discuss the operating results and updates on ongoing programs. The results will be released before the U.S. markets open that day.

Market Sentiment Analysis

POSITIVE FACTORS

  • Palatin will share its first quarter fiscal results, indicating transparency.
  • The company is hosting a teleconference to provide updates on development programs.
  • Palatin focuses on first-in-class medicine for significant unmet medical needs.

Full Press Release Details

CRANBURY, N.J., Nov. 8, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter fiscal year 2025 operating results on Thursday, November 14, 2024, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 14, 2024, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
Q1 Fiscal Year 2025 Results Press Release 11/14/2024 at 7:30 a.m. ET
Q1 Fiscal Year 2025 Conference Call-Live 11/14/2024 at 11:00 a.m. ET
US Toll Free Dial-In Number: 1-888-506-0062
International Dial-In Number: 1-973-528-0011
Participant Access Code: 176159
Q1 Fiscal Year 2025 Conference Call-Replay 11/14/2024-11/28/2024
US Toll Free Dial-In Number: 1-877-481-4010
International Dial-In Number: 1-919-882-2331
Participant Access Code: 51641
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
SOURCE Palatin Technologies, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Palatin Technologies announce Q1 FY 2025 results?

Palatin Technologies will announce its Q1 FY 2025 results on November 14, 2024.

What time is the Palatin conference call on November 14, 2024?

The conference call on November 14, 2024, is scheduled for 11:00 a.m. ET.

How can I access the audio webcast of Palatin's results?

The audio webcast can be accessed via the 'Investors-Webcasts' section on Palatin's website.

What is Palatin's focus in biopharmaceutical development?

Palatin develops first-in-class medicines targeting melanocortin receptor systems.

How can I join the conference call replay?

The replay is available from November 14 to November 28, 2024, using provided dial-in numbers.

Last updated: Nov 8, 2024